-
Inhaled Anti-Fungal Drug Shown Safe for People with Asthma
Results from a clinical trial show an inhaled form of a current anti-fungal drug to treat a complication of asthma is safe for patients, including those with asthma.
-
Hydrogel Developed for Lower-Cost Wound Healing
An engineering lab develop a new hydrogel with readily available materials that in lab tests promotes healing of wounds similar to those encountered by people with diabetes.
-
Protecting Your Commercial Property
There are steps that you can implement into your business that will help to protect your commercial property and reduce its chances of being damaged through criminal activity.
-
NSF Supports Expanding Lab-On-Chip Integration, Manufacturing Center
A new federal grant supports expansion of a research and development center developing techniques to make the manufacture and integration of microfluidic, or lab-on-a-chip, devices easier and less expensive.
-
RNA Therapy Helps Reduce Preeclampsia Symptoms
Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women.
-
Keeping Your Business Safe Online
Let’s take a look at some of the essential things you need to be sure of if you are to keep your business as safe in the online world as possible.
-
Report – U.S. Lags in Robotic Adoption
A report released today shows the U.S. and most European countries are falling behind most other developed countries, in adopting robotics into their economies.
-
Trial Shows Treatment Prevents Peanut Allergy Reactions
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year.
-
What Jobs Are Most Secure For The Future?
Fear not, because there are some jobs that are less likely to be affected by the rise of the machines.
-
Update – Verily Suspends Glucose-Sensing Contact Lens Project
An initiative developing a contact lens that measures blood glucose levels in tear fluid is now on hold, according to Verily Life Sciences, a division of Alphabet, the parent company of Google.